A role reversal in biotech patenting

The difference in the patenting landscape between the United States and Europe used to be characterized as freewheeling versus cautionary; expansive versus patchwork. Think of Diamond v. Chakrabarty‘s “anything under the sun that is made by man” versus the long battle to finally allow the patenting of stem cells in Europe. Read more
Recent comments on this blog
New Trump Travel Ban a Detriment to Biotech
More on the Shelf
My Biotech Heroes